Siegel RL, Miller KD, Jemal A. Most cancers statistics, 2018. CA Most cancers J. Clin. 2018;68:7–30.
Byrne M, Saif MW. Choosing therapy choices in refractory metastatic colorectal most cancers. OncoTargets Ther. 2019;12:2271–8.
Strum WB. Colorectal adenomas. N Engl J Med. 2016;374:1065–75.
Hauptman N, Boštjančič E, Žlajpah M, Ranković B, Zidar N. Bioinformatics evaluation reveals most outstanding gene candidates to tell apart colorectal adenoma from adenocarcinoma. BioMed Res Int. 2018;2018:9416515.
Lo Nigro C, Ricci V, Vivenza D, Granetto C, Fabozzi T, Miraglio E, et al. Prognostic and predictive biomarkers in metastatic colorectal most cancers anti-EGFR remedy. World J Gastroenterol. 2016;22:6944–54.
Mutch MG. Molecular profiling and danger stratification of adenocarcinoma of the colon. J Surg Oncol. 2007;96:693–703.
Alaiyan B, Ilyayev N, Stojadinovic A, Izadjoo M, Roistacher M, Pavlov V, et al. Differential expression of colon most cancers related transcript1 (CCAT1) alongside the colonic adenoma-carcinoma sequence. BMC Most cancers. 2013;13:196.
Maley CC, Aktipis A, Graham TA, Sottoriva A, Boddy AM, Janiszewska M, et al. Classifying the evolutionary and ecological options of neoplasms. Nat Rev Most cancers. 2017;17:605–19.
Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans Okay, et al. ESMO Consensus Tips for administration of sufferers with colon and rectal most cancers. a personalised strategy to scientific determination making. Ann Oncol. 2012;23:2479–516.
Khan U, Chowdhury S, Billah MM, Islam KMD, Thorlacius H, Rahman M. Neutrophil extracellular traps in colorectal most cancers development and metastasis. Int J Mol Sci. 2021;22:7260.
Kawada Okay, Hosogi H, Sonoshita M, Sakashita H, Manabe T, Shimahara Y, et al. Chemokine receptor CXCR3 promotes colon most cancers metastasis to lymph nodes. Oncogene. 2007;26:4679–88.
Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, et al. Pre-metastatic niches: organ-specific houses for metastases. Nat Rev Most cancers. 2017;17:302–17.
Leal JN, Bressan AK, Vachharajani N, Gonen M, Kingham TP, D’Angelica MI, et al. Time-to-surgery and survival outcomes in resectable colorectal liver metastases: a multi-institutional analysis. J. Am Coll Surg. 2016;222:766–79.
Gene Ontology Consortium. Gene Ontology Consortium: going ahead. Nucleic Acids Res. 2015;43:D1049–56.
Nelson DR, Teckman J, Di Bisceglie AM, Brenner DA. Analysis and administration of sufferers with α1-antitrypsin (A1AT) deficiency. Clin Gastroenterol Hepatol. 2012;10:575–80.
Guillaud O, Dumortier J, Traclet J, Restier L, Joly P, Chapuis-Cellier C, et al. Evaluation of liver fibrosis by transient elastography (Fibroscan(®)) in sufferers with A1AT deficiency. Clin Res Hepatol Gastroenterol. 2019;43:77–81.
Curjuric I, Imboden M, Bettschart R, Caviezel S, Dratva J, Pons M, et al. Alpha-1 antitrypsin deficiency: From the lung to the guts? Atherosclerosis. 2018;270:166–72.
Greene CM, McElvaney NG. Protein misfolding and obstructive lung illness. Proc Am Thorac Soc. 2010;7:346–55.
Berger M, Liu M, Uknis ME, Koulmanda M. Alpha-1-antitrypsin in cell and organ transplantation. Am J Transplant. 2018;18:1589–95.
Ercetin E, Richtmann S, Delgado BM, Gomez-Mariano G, Wrenger S, Korenbaum E, et al. Scientific significance of SERPINA1 gene and its encoded alpha1-antitrypsin protein in NSCLC. Cancers. 2019;11:1306.
Xie LQ, Zhao C, Cai SJ, Xu Y, Huang LY, Bian JS, et al. Novel proteomic technique reveal mixed alpha1 antitrypsin and cathepsin D as biomarkers for colorectal most cancers early screening. J Proteome Res. 2010;9:4701–9.
Kwon CH, Park HJ, Choi JH, Lee JR, Kim HK, Jo HJ, et al. Snail and serpinA1 promote tumor development and predict prognosis in colorectal most cancers. Oncotarget. 2015;6:20312–26.
Li J, Du J, Wang Y, Jia H. A coagulation-related gene-based prognostic mannequin for invasive ductal carcinoma. Entrance Genet. 2021;12:722992.
Wu L, Zhou Y, Guan Y, Xiao R, Cai J, Chen W, et al. Seven genes related to lymphatic metastasis in thyroid most cancers that’s linked to tumor immune cell infiltration. Entrance Oncol. 2021;11:756246.
Corvinus FM, Orth C, Moriggl R, Tsareva SA, Wagner S, Pfitzner EB, et al. Persistent STAT3 activation in colon most cancers is related to enhanced cell proliferation and tumor development. Neoplasia. 2005;7:545–55.
De Simone V, Franzè E, Ronchetti G, Colantoni A, Fantini MC, Di Fusco D, et al. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to advertise colorectal most cancers cell development. Oncogene. 2015;34:3493–503.
Zhi L, Zhao L, Zhang X, Liu W, Gao B, Wang F, et al. SLCO1B3 promotes colorectal most cancers tumorigenesis and metastasis by way of STAT3. Getting older. 2021;13:22164–75.
El-Tanani M, Al Khatib AO, Aladwan SM, Abuelhana A, McCarron PA, Tambuwala MM. Significance of STAT3 signalling in most cancers, metastasis and therapeutic interventions. Cell Sign. 2022;92:110275.
Morikawa T, Baba Y, Yamauchi M, Kuchiba A, Nosho Okay, Shima Okay, et al. STAT3 expression, molecular options, irritation patterns, and prognosis in a database of 724 colorectal cancers. Clin. Most cancers Res. 2011;17:1452–62.
Liu W, Geng C, Li X, Li Y, Track S, Wang C. Downregulation of SLC9A8 promotes epithelial-mesenchymal transition and metastasis in colorectal most cancers cells by way of the IL6-JAK1/STAT3 signaling pathway. Dig Dis Sci. 2023;68:1873–84.
Hashemi V, Masjedi A, Hazhir-Karzar B, Tanomand A, Shotorbani SS, Hojjat-Farsangi M, et al. The position of DEAD-box RNA helicase p68 (DDX5) within the improvement and therapy of breast most cancers. J Cell Physiol. 2019;234:5478–87.
Wu QN, Luo XJ, Liu J, Lu YX, Wang Y, Qi J, et al. MYC-activated LncRNA MNX1-AS1 Promotes the development of colorectal most cancers by stabilizing YB1. Most cancers Res. 2021;81:2636–50.
Zhai D, Cui C, Xie L, Cai L, Yu J. Sterol regulatory element-binding protein 1 cooperates with c-Myc to advertise epithelial-mesenchymal transition in colorectal most cancers. Oncol Lett. 2018;15:5959–65.
Tan L, Peng D, Cheng Y. Vital place of C-myc in colorectal most cancers: a promising therapeutic goal. Clin Transl Oncol. 2022;24:2295–304.
Attanasio S, Ferriero R, Gernoux G, De Cegli R, Carissimo A, Nusco E, et al. CHOP and c-JUN up-regulate the mutant Z α(1)-antitrypsin, exacerbating its aggregation and liver proteotoxicity. J Biol Chem. 2020;295:13213–23.
Lin H, Liu S, Gao W, Liu H. DDIT3 modulates most cancers stemness in gastric most cancers by straight regulating CEBPβ. J Pharm Pharmacol. 2020;72:807–15.
Jin B, Gong Y, Li H, Jiao L, Xin D, Gong Y, et al. C/EBPβ promotes the viability of human bladder most cancers cell by contributing to the transcription of bladder most cancers particular lncRNA UCA1. Biochem Biophys Res Commun. 2018;506:674–9.
Qin M, Han F, Wu J, Gao FX, Li Y, Yan DX, et al. KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPβ transcription. BMC Most cancers. 2021;21:559.
Lei Okay, Xia Y, Wang XC, Ahn EH, Jin L, Ye Okay. C/EBPβ mediates NQO1 and GSTP1 anti-oxidative reductases expression in glioblastoma, selling mind tumor proliferation. Redox Biol. 2020;34:101578.
Lei Okay, Kang SS, Ahn EH, Chen C, Liao J, Liu X, et al. C/EBPβ/AEP signaling regulates the oxidative stress in malignant cancers, stimulating the metastasis. Mol Most cancers Ther. 2021;20:1640–52.
Okazaki Okay, Anzawa H, Katsuoka F, Kinoshita Okay, Sekine H, Motohashi H. CEBPB is required for NRF2-mediated drug resistance in NRF2-activated non-small cell lung most cancers cells. J. Biochem. 2022;171:567–78.
Del Rio M, Mollevi C, Vezzio-Vie N, Bibeau F, Ychou M, Martineau P. Particular extracellular matrix reworking signature of colon hepatic metastases. PLoS One. 2013;8:e74599.
Vlachavas EI, Pilalis E, Papadodima O, Koczan D, Willis S, Klippel S, et al. Radiogenomic evaluation of F-18-fluorodeoxyglucose positron emission tomography and gene expression knowledge elucidates the epidemiological complexity of colorectal most cancers panorama. Comput Struct Biotechnol J. 2019;17:177–85.
Solar Z, Xia W, Lyu Y, Track Y, Wang M, Zhang R, et al. Immune-related gene expression signatures in colorectal most cancers. Oncol Lett. 2021;22:543.
Galamb O, Sipos F, Solymosi N, Spisák S, Krenács T, Tóth Okay, et al. Diagnostic mRNA expression patterns of infected, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood outcomes. Most cancers Epidemiol Biomark Prev. 2008;17:2835–45.
Smith JJ, Deane NG, Wu F, Service provider NB, Zhang B, Jiang A, et al. Experimentally derived metastasis gene expression profile predicts recurrence and demise in sufferers with colon most cancers. Gastroenterology. 2010;138:958–68.
Staub E, Groene J, Heinze M, Mennerich D, Roepcke S, Klaman I, et al. An expression module of WIPF1-coexpressed genes identifies sufferers with favorable prognosis in three tumor sorts. J Mol Med. 2009;87:633–44.
Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 2007;23:1846–7.
Ritchie ME, Phipson B, Wu D, Hu Y, Legislation CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray research. Nucleic Acids Res. 2015;43:e47.
Tomczak Okay, Czerwińska P, Wiznerowicz M. The Most cancers Genome Atlas (TCGA): an immeasurable supply of information. Contemp Oncol. 2015;19:A68–77.
Robinson MD, McCarthy DJ, Smyth GKJB. edgeR: a bioconductor package deal for differential expression evaluation of digital gene expression knowledge. Bioinformatics. 2010;26:139–40.
Liberzon A, Birger C, Thorvaldsdóttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set assortment. Cell Syst. 2015;1:417–25.
Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation evaluation for microarray and RNA-seq knowledge. BMC Bioinform. 2013;14:1–15.
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment evaluation: a knowledge-based strategy for deciphering genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545–50.
Brown GR, Hem V, Katz KS, Ovetsky M, Wallin C, Ermolaeva O, et al. Gene: a gene-centered data useful resource at NCBI. Nucleic Acids Res. 2015;43:D36–42.
